Fwu Chyng-Wen, Schulman Ivonne H, Lawrence Jean M, Kimmel Paul L, Eggers Paul, Norton Jenna, Chan Kevin, Mendley Susan R, Barthold Julia S
Social & Scientific Systems, Inc, A DLH Holdings Corp (DLH) Company, Silver Spring, Maryland.
Division of Kidney, Urologic & Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
J Urol. 2024 Jan;211(1):124-133. doi: 10.1097/JU.0000000000003761. Epub 2023 Oct 20.
Diabetes and obesity, components of the metabolic syndrome (MetS), are risk factors for urinary incontinence (UI) and chronic kidney disease (CKD). We interrogated US population-based data to explore independent, sex-specific associations between nondiabetic MetS, with and without obesity, and UI and/or CKD.
We analyzed data from 8586 males and 8420 females ≥20 years from the National Health and Nutrition Examination Survey. Multivariable logistic regression models were used to examine associations of UI or CKD with diabetes and 4 nondiabetic obesity/metabolic phenotypes: non-MetS/nonobese, MetS/nonobese, non-MetS/obese, and MetS/obese. Multinominal logistic regression models were used to assess associations of co-occurring UI/CKD with obesity/metabolic phenotypes.
Male MetS/obese participants had increased odds of any UI (1.25; 95% CI 1.00-1.57) and urgency UI (1.36; 1.03-1.80), compared with non-MetS/nonobese participants. Female MetS/obese participants had increased odds of any UI (2.16; 95% CI 1.76-2.66), stress UI (1.51; 1.21-1.87), and mixed UI (1.66; 1.31-2.11) compared with non-MetS/nonobese participants. The odds of co-occurring UI/CKD were increased relative to either condition alone in persons with diabetes, and in males with MetS/obese phenotypes and females with MetS phenotypes as compared to same sex participants with neither obesity nor MetS.
We found novel associations between MetS/obese and urgency UI in males without diabetes, and between SUI and both MetS and obesity in females without diabetes. Odds estimates for UI/CKD were increased by existing obesity or MetS as compared to those for UI or CKD alone. Improved understanding of modifiable factors associated with UI will inform prevention and treatment opportunities.
糖尿病和肥胖作为代谢综合征(MetS)的组成部分,是尿失禁(UI)和慢性肾脏病(CKD)的危险因素。我们分析了基于美国人群的数据,以探究非糖尿病性MetS(伴或不伴肥胖)与UI和/或CKD之间独立的、性别特异性的关联。
我们分析了来自美国国家健康与营养检查调查中年龄≥20岁的8586名男性和8420名女性的数据。使用多变量逻辑回归模型来检验UI或CKD与糖尿病以及4种非糖尿病性肥胖/代谢表型之间的关联:非MetS/非肥胖、MetS/非肥胖、非MetS/肥胖和MetS/肥胖。使用多项逻辑回归模型来评估同时发生的UI/CKD与肥胖/代谢表型之间的关联。
与非MetS/非肥胖参与者相比,男性MetS/肥胖参与者发生任何UI(比值比1.25;95%置信区间1.00 - 1.57)和急迫性UI(比值比1.36;1.03 - 1.80)的几率增加。与非MetS/非肥胖参与者相比,女性MetS/肥胖参与者发生任何UI(比值比2.16;95%置信区间1.76 - 2.66)、压力性UI(比值比1.51;1.21 - 1.87)和混合性UI(比值比1.66;(1.31 - 2.11)的几率增加。与既无肥胖也无MetS的同性参与者相比,糖尿病患者以及具有MetS/肥胖表型的男性和具有MetS表型的女性同时发生UI/CKD的几率相对于单独发生任何一种疾病的几率都有所增加。
我们发现,在无糖尿病的男性中,MetS/肥胖与急迫性UI之间存在新的关联;在无糖尿病的女性中,压力性UI与MetS和肥胖均有关联。与单独的UI或CKD相比,现有的肥胖或MetS会增加UI/CKD的几率估计值。对与UI相关的可改变因素的更好理解将为预防和治疗提供依据。